lunes, 12 de marzo de 2018

Marketing Science | Scientific Marketing | Company | Experts

Marketing Science | Scientific Marketing | Company | Experts



 
 March 12, 2018 
 Genomics 
 The latest genomics news from AZoNetwork 
 #ALT#Normalization in qPCR Using Passive Reference Dyes

Passive reference dyes are usually used in qPCR reactions to normalize for non-PCR related fluorescence signal difference. This article looks at the history and uses of passive reference dyes for normalization in qPCR.

Read More
 
   Hamilton Robotics Launch ID NIMBUS® for Forensic Genomics ApplicationsHamilton Robotics Launch ID NIMBUS® for Forensic Genomics Applications
 
Hamilton Robotics announce the release of the ID NIMBUS® assay ready workstation, specifically pre-configured and qualified to automate post-PCR sample processing using the Verogens renowned ForenSeq DNA Signature Prep Kit.
 
   BC Platforms' new GeneVision uses Microsoft Genomics Service to deliver end-to-end precision medicineBC Platforms' new GeneVision uses Microsoft Genomics Service to deliver end-to-end precision medicine
 
BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure.
 
 Benson Hill Biosystems granted patent for novel genome editing system
 
Benson Hill Biosystems granted patent for novel genome editing systemThe U.S. Patent and Trademark Office has granted Benson Hill Biosystems Patent No. 9,896,696 related to CRISPR 3.0 Cms1 genome editing nucleases, further expanding the company's suite of genomics tools to accelerate crop performance improvements.
 
 
 Researchers discover 50 new gene regions that increase risk of schizophrenia
 
Researchers discover 50 new gene regions that increase risk of schizophreniaResearchers at the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University have discovered 50 new gene regions that increase the risk of developing schizophrenia.
 
 
 Ground-breaking partnership aims to deliver faster, more accurate diagnoses for genetic epilepsy
 
Ground-breaking partnership aims to deliver faster, more accurate diagnoses for genetic epilepsyNew software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
 
 
 Tissue-specific changes in gene expression can help predict time of death
 
Tissue-specific changes in gene expression can help predict time of deathInternational team of scientists led by Roderic Guigó at the Centre for Genomic Regulation in Barcelona showed that changes in gene expression in different tissues triggered by death can be used to predict the time of death of an individual.
 

No hay comentarios:

Publicar un comentario